HIGHLIGHTS
- who: Victoria Vinader and collaborators from the Institute of Cancer Therapeutics, University of Bradford, Bradford, United Kingdom have published the research work: Discovery and Computer Aided Potency Optimization of a Novel Class of Small Molecule CXCR4 Antagonists, in the Journal: PLOS ONE | www.plosone.org of October/18,/2013
- what: Molecular modelling proved to be a useful tool in rationalising the observed potencies as well as informing the direction of the synthetic efforts aimed at producing more potent compounds. The authors report the identification of ICT5040 a new CXCR4 antagonist chemotype, identified through in silico . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.